Nicole LaBrosse - Feb 23, 2024 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF FINANCIAL OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Feb 23, 2024
Transactions value $
$0
Form type
4
Date filed
2/27/2024, 05:05 PM
Previous filing
Feb 20, 2024
Next filing
Jun 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Option to Purchase Common Stock Award $0 +27.7K $0.00 27.7K Feb 23, 2024 Common Stock 27.7K $40.56 Direct F1
transaction HALO Restricted Stock Units Award $0 +26.8K $0.00 26.8K Feb 23, 2024 Common Stock 26.8K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests one-fourth on such date and then 1/48th monthly thereafter.
F2 This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.